Inhibition of Nonsense-Mediated Decay Rescues Functional P53β/γ Isoforms in MDM2-amplified Cancers
Jayanthi Gudikote,Tina Cascone,Alissa Poteete,Piyada Sitthideatphaiboon,Qiuyu Wu,Naoto Morikawa,Fahao Zhang,Shaohua Peng,Pan Tong,Lerong Li,Ли Шен,Monique B. Nilsson,Philip H. Jones,Erik P. Sulman,Jing Wang,Jean‐Christophe Bourdon,Faye M. Johnson,John V. Heymach
DOI: https://doi.org/10.1101/2020.04.06.026955
2020-01-01
Abstract:ABSTRACT Common mechanisms for p53 loss in cancer include expression of MDM2 or the human papilloma virus (HPV)-encoded E6 protein which both mediate degradation of wild-type (WT) p53 (p53α). Here, we show that two alternatively-spliced, functional, truncated isoforms of p53 (p53β and p53γ, containing exons 1-9 of the p53 gene) can be markedly upregulated by pharmacologic or genetic inhibition of nonsense mediated decay (NMD), a regulator of aberrant mRNA stability. These isoforms lack the MDM2 binding domain and hence have reduced susceptibility to MDM2-mediated degradation. In MDM2-overexpressing cells bearing wildtype TP53 gene, NMD blockade increased p53β/γ expression and p53 pathway activation, enhanced radiosensitivity, and inhibited tumor growth. A similar pattern was observed in HPV + cancer cells and in cancer cells with p53 mutations downstream of exon 9. These results identify a novel therapeutic strategy for restoration of p53 function in tumors rendered p53 deficient through MDM2 overexpression, HPV infection, or certain p53 mutations.